Rathbones Group PLC Imv Inc. Transaction History

Rathbones Group PLC

  • $19 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021
SELL
$2.9 - $4.4 $45,312 - $68,750
-15,625 Closed
0 $0
Q4 2018

Feb 12, 2019
BUY
$4.93 - $6.34 $77,031 - $99,062
15,625 New
15,625 $79,000

About IMV Inc.

IMV Quotes by TradingView
  • Ticker IMV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,452,200
  • Description
  • IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...
More about IMV
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email